Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Highly Endocrine Responsive Operable Breast Cancer × Tablets × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Triple Negative Breast Neoplasms 2 Cardiotoxicity 2 Ovarian Neoplasms 1 Obesity 1 Inflammation 1 Hot Flashes 1 Highly Endocrine Responsive Operable Breast Cancer 1 Genetic Diseases, Inborn 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Advanced Breast Cancer 1

Interventions

Tablets 1 Letrozole 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Guangdong Provincial People's Hospital

Phase 2 Completed

Highly Endocrine Responsive Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡